Emmaus Life Sciences EMMA
OTC EMMA
$0.05 -0.01 (-16.67%)
At close: Oct 19, 2026 · 4:00 PM EDT

Emmaus Life Sciences (EMMA) Non-Current Assets (2010 - 2026)

Updated

Emmaus Life Sciences (EMMA) posted Non-Current Assets of $10.37 million for Q2 2026, down 43.4% from $18.33 million a year earlier and down 18.4% from the prior quarter.

Analysis

Emmaus Life Sciences (EMMA) Non-Current Assets (2010 - 2026) Analysis & Trends

At the end of FY2025, Emmaus Life Sciences' Non-Current Assets came in at $13.69 million, down 18.7% from FY2024.

  • Annual Non-Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -22.3% (FY2020 to FY2025).
  • In prior years, Emmaus Life Sciences' Non-Current Assets was $16.84 million in FY2024 (-28.9%), $23.67 million in FY2023 (-43.6%), $41.94 million in FY2022 (-12.0%) and $47.64 million in FY2021 (-1.3%).
  • The Q2 2026 figure stands as the lowest quarterly Non-Current Assets since Q3 2018.
  • On a year-over-year basis, Non-Current Assets has declined in each of the last four quarters, with an average decline of 24.3% over the last eight quarters.
  • The strongest year-over-year quarter for Non-Current Assets in the past five years was Q3 2021, with growth of 149.8%; the weakest was Q2 2024, with a decline of 58.1%.
  • According to Business Quant data, Non-Current Assets for the three prior quarters was $12.7 million (Q1 2026), $13.69 million (Q4 2025) and $15.97 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Emmaus Life Sciences 3.51 Mn -2.79 Mn 5.97 Mn 10.37 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 10.37 Mn
Mar 31, 2026 12.70 Mn
Dec 31, 2025 13.69 Mn
Sep 30, 2025 15.97 Mn
Jun 30, 2025 18.33 Mn
Mar 31, 2025 16.83 Mn
Dec 31, 2024 16.84 Mn
Sep 30, 2024 18.14 Mn
Jun 30, 2024 16.93 Mn
Mar 31, 2024 21.70 Mn
Dec 31, 2023 23.67 Mn
Sep 30, 2023 38.20 Mn
Jun 30, 2023 40.44 Mn
Mar 31, 2023 41.53 Mn
Dec 31, 2022 41.94 Mn
Sep 30, 2022 35.82 Mn
Jun 30, 2022 39.40 Mn
Mar 31, 2022 45.05 Mn
Dec 31, 2021 47.64 Mn
Sep 30, 2021 47.58 Mn
API Access

Emmaus Life Sciences Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=EMMA&period=max&api_key=YOUR_API_KEY